International Journal for Quality in Health Care Advance Access originally published online on June 28, 2005
International Journal for Quality in Health Care 2005 17(6):505-509; doi:10.1093/intqhc/mzi061
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Evaluating claims-based indicators of the intensity of end-of-life cancer care
1 Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA, 2 Department of Health Care Policy, Harvard Medical School, Boston, MA, USA, 3 Division of Psychosocial Oncology and Palliative Care, Department of Psychiatry, Brigham and Women’s Hospital, Boston, MA, USA, 4 Dalhousie University and Cancer Care Nova Scotia, Halifax, Nova Scotia, Canada, and 5 Division of General Medicine, Department of Medicine, Brigham and Women’s Hospital, Boston, MA, USA
Objective. To evaluate measures that could use existing administrative data to assess the intensity of end-of-life cancer care.
Methods. Benchmarking standards and statistical variation were evaluated using Medicare claims of 48,906 patients who died from cancer from 1991 through 1996 in 11 regions of the United States. We assessed accuracy by comparing administrative data to 150 medical records in one hospital and affiliated cancer treatment center.
Results. Systems not providing overly aggressive care near the end of life would be ones in which less than 10% of patients receive chemotherapy in the last 14 days of life, less than 2% start a new chemotherapy regimen in the last 30 days of life, less than 4% have multiple hospitalizations or emergency room visits or are admitted to the intensive care unit (ICU) in the last month of life, and less than 17% die in an acute care institution. At least 55% of patients would receive hospice services before death from cancer, and less than 8% of those would be admitted to hospice within only 3 days of death. All measures were found to have accuracy ranging from 85 to 97% and 2- to 5-fold adjusted variability between the 5th and 95th percentiles of performance.
Conclusions. The usefulness of these measures will depend on whether the concept of intensity of care near death can be further validated as an acceptable and important quality issue among patients, their families, health care providers, and other stakeholders in oncology.
Keywords: administrative data, benchmarking, cancer, claims data, indicators development, performance measures, quality of care, terminally ill patients
Address reprint requests to Craig C. Earle, MD MSc, Center for Outcomes and Policy Research, Dana-Farber Cancer Center, 44 Binney st., 454-STE 21-24, Boston, MA, 02115. E-mail: craig_earle{at}dfci.harvard.edu
Accepted for publication May 26, 2005.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  C. C. Earle, M. B. Landrum, J. M. Souza, B. A. Neville, J. C. Weeks, and J. Z. Ayanian Aggressiveness of Cancer Care Near the End of Life: Is It a Quality-of-Care Issue? J. Clin. Oncol., August 10, 2008; 26(23): 3860 - 3866. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Miyashita, A. Nakamura, T. Morita, and S. Bito Identification of Quality Indicators of End-of-Life Cancer Care From Medical Chart Review Using a Modified Delphi Method in Japan American Journal of Hospice and Palliative Medicine, March 1, 2008; 25(1): 33 - 38. [Abstract] [PDF]
|
|
|
|
 |
|
 D.M.W. Tse, K.S. Chan, W.M. Lam, K. Leu, and P.T. Lam The impact of palliative care on cancer deaths in Hong Kong: a retrospective study of 494 cancer deaths Palliative Medicine, July 1, 2007; 21(5): 425 - 433. [Abstract] [PDF]
|
|
|
|
|
|
K. A. Lorenz, J. Lynn, S. Dy, A. Wilkinson, R. A. Mularski, L. R. Shugarman, R. Hughes, S. M. Asch, C. Rolon, A. Rastegar, et al. Quality Measures for Symptoms and Advance Care Planning in Cancer: A Systematic Review J. Clin. Oncol., October 20, 2006; 24(30): 4933 - 4938. [Abstract] [Full Text] [PDF]
|
|